Achieving Higher Diagnostic Results in Stereotactic Brain Biopsy by Simple and Novel Technique

Salih Gulsen

doi:10.3889/oamjms.2015.016

Authors

Salih Gulsen Baskent University Medical Faculty Hospital - Neurosurgery, Maresal Fevzi Cakmak cad. 10. sok. No: 45, Ankara 06540

DOI:

https://doi.org/10.3889/oamjms.2015.016

Keywords:

Brain Tumour, Diffuse infilitrative, Eloquent Areas, Stereotactic Biopsy, Diagnostic rate

Abstract

BACKGROUND: Neurosurgeons have preferred to perform the stereotactic biopsy for pathologic diagnosis when the intracranial pathology located eloquent areas and deep sites of the brain.

AIM: To get a higher ratio of definite pathologic diagnosis during stereotactic biopsy and develop practical method.

MATERIAL AND METHODS: We determined at least two different target points and two different trajectories to take brain biopsy during stereotactic biopsy. It is a different way from the conventional stereotactic biopsy method in which one point has been selected to take a biopsy. We separated our patients into two groups, group 1 (N=10), and group 2 (N= 19). We chose one target to take a biopsy in group 1, and two different targets and two different trajectories in group 2. In group 2, one patient underwent craniotomy due to hemorrhage at the site of the biopsy during tissue biting. However, none of the patients in both groups suffered any neurological complication related biopsy procedure.

RESULTS: In group 1, two of 10 cases, and, in group 2, fourteen of 19 cases had positive biopsy harvesting. These results showed statistically significant difference between group 1 and group 2 (P<0.05).

CONCLUSIONS: Regarding these results, choosing more than one trajectories and taking at least six specimens from each target provides higher diagnostic rate in stereotaxic biopsy taking method.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Apuzzo ML, Sabshin JK. Computed tomographic guidance stereotaxis in the management of intracranial mass lesions. Neurosurgery. 1983; 12: 277-85. DOI: https://doi.org/10.1227/00006123-198303000-00005

Ostertag CB, Mennel HD, Kiessling M Stereotactic biopsy of brain tumors. Surg Neurol. 1980; 14: 275â€“83.

Edner G. Stereotactic biopsy of intracranial space occupying lesions. Acta Neurochir (Wien). 1981;57: 213â€“34. DOI: https://doi.org/10.1007/BF01664839

Grunert P, Ungersbock K, Bohl J, Kitz K, Hopf N. Results of 200 intracranial stereotactic biopsies. Neurosurgery. 1994; 17: 59-66. DOI: https://doi.org/10.1007/BF00309989

Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer. 1998; 82: 1749-55.

Kim JE, Kim DG, Paek SH, Abd Jung HW. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir (Wien). 2003; 145: 547-54. DOI: https://doi.org/10.1007/s00701-003-0048-8

Jackson RJ, Fuller GN, Abi-Said D, Lang FF, Gokaslan ZL, Shi WM, Wildrick DM, Sawaya R. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-oncol. 2001; 3: 193-200. DOI: https://doi.org/10.1093/neuonc/3.3.193

Scerrati M, Rossi G. The reliability of stereotactic biopsy. Acta Neurochir Suppl. 1984; 33: 201â€“5. DOI: https://doi.org/10.1007/978-3-7091-8726-5_29

Smith JS, QuiÃ±ones-Hinojosa A, Barbaro NM, McDermott MW. Frame-based stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy. J Neurooncol. 2005;73: 173-9. DOI: https://doi.org/10.1007/s11060-004-4208-3

Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer. 1998;82: 1749â€“55. DOI: https://doi.org/10.1002/(SICI)1097-0142(19980501)82:9<1756::AID-CNCR23>3.0.CO;2-2

Grossman R, Sadetzki S, Spiegelmann R, Ram Z. Hemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir (Wien). 2005; 147:627â€“31. DOI: https://doi.org/10.1007/s00701-005-0495-5

Waters JD, Gonda DD, Reddy H, Kasper EM, Warnke PC, Chen CC. Diagnostic yield of stereotactic needle-biopsies of sub-cubic centimeter intracranial lesions. Surg Neurol Int. 2013; 17: 176-81. DOI: https://doi.org/10.4103/2152-7806.110677

McGirt MJ, Woodworth GF, Coon AL, Frazier JM, Amundson E, Garonzik I, Olivi A, Weingart JD Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg. 2005; 102:897â€“901. DOI: https://doi.org/10.3171/jns.2005.102.5.0897

Zacest A, Berk C, Burchiel KJ. Precision and accuracy of stereotactic targeting in patients undergoing repeat stereotactic surgery. Stereotact Funct Neurosurg. 2009; 87:168-73. DOI: https://doi.org/10.1159/000215932

Kim SH, Chang WS, Kim JP, Minn YK, Choi J, Chang JW, Kim TS, Park YG, Chang JH. Peripheral compressing artifacts in brain tissue from stereotactic biopsy with side cutting biopsy needle: A pitfall for adequate glioma grading. Clin Neuropathol. 2011;30: 328-32. DOI: https://doi.org/10.5414/NP300404

Cappabianca, P, Spaziante, R, Caputi, F. Accuracy of the analysis of multiple small fragments of glial tumors obtained by stereotactic biopsy. Acta Cyto. 1991; 35: 505-11.

Woodworth G, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD. Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res. 2005; 27: 358â€“62. DOI: https://doi.org/10.1179/016164105X40057

Ferreira MP, Ferreira NP, Pereira Filho Ade A, Pereira Filho Gde A, Franciscatto AC. Stereotactic computerized tomography guided brain biopsy: diagnostic yield based on a series of 170 patients. Surg Neurol. 2006; 65:27â€“32. DOI: https://doi.org/10.1016/j.surneu.2005.11.036

Jain D, Sharma MC, Sarkar C, Deb P, Gupta D, Mahapatra AK. Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion. Brain Tumor Pathol. 2006; 23:71â€“5. DOI: https://doi.org/10.1007/s10014-006-0204-y

Dammers R, Schouten JW, Haitsma IK, Vincent AJ, Kros JM, Dirven CM. Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre. Acta Neurochir. 2010; 152:1915â€“21. DOI: https://doi.org/10.1007/s00701-010-0752-0

Collaco LM, Tani E, Lindblom I, Skoog L. Stereotactic biopsy and cytological diagnosis of solid and cystic intracranial lesions. Cytopathology. 2003; 14:131â€“5. DOI: https://doi.org/10.1046/j.1365-2303.2003.00046.x

Zoeller GK, Benveniste RJ, Landy H, Morcos JJ, Jagid J. Outcomes and management strategies after nondiagnostic stereotactic biopsies of brain lesions. Stereotact Funct Neurosurg. 2009; 87:174-81. DOI: https://doi.org/10.1159/000222661

Woodworth GF, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD. Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique. J Neurosurg. 2006; 104:233â€“7. DOI: https://doi.org/10.3171/jns.2006.104.2.233

Gaudin PB, Sherman ME, Brat DJ, Zahurak M, Erozan YS. Accuracy of grading gliomas on CT-guided stereotactic biopsies: a survival analysis. Diagn Cytopathol. 1997; 17:461- 6. DOI: https://doi.org/10.1002/(SICI)1097-0339(199712)17:6<461::AID-DC16>3.0.CO;2-K

Soo TM, Bernstein M, Provias J, Tasker R, Lozano A, Guha A. Failed stereotactic biopsy in a series of 518 cases. Stereotact Funct Neurosurgery. 1995; 64:183-96.

Takahashi H, Sugai T, Uzuka T, Kano M, Honma J, Grinev I, Tanaka R. Complications and diagnostic yield of stereotactic biopsy for the patients with malignant brain tumors. No Shinkei Geka. 2004; 32: 135-40.